综述

多不饱和脂肪酸代谢及其对炎症的调节

  • 弓剑 ,
  • 晓敏
展开
  • 内蒙古师范大学生命科学与技术学院, 呼和浩特 010022

收稿日期: 2016-07-14

  网络出版日期: 2017-01-16

基金资助

国家自然科学基金项目(31560644);内蒙古自然科学基金项目(2015MS0367);引进高层次人才科研启动经费项目(2015YJRC005)

The Metabolism of Polyunsaturated Fatty Acids and Its Regulation to Inflammation

  • GONG Jian ,
  • XIAO Min
Expand
  • College of Life Science and Technology, Inner Mongolia Normal University, Huhhot 010022, China

Received date: 2016-07-14

  Online published: 2017-01-16

摘要

炎症是一种机体对感染或组织损伤的保护性反应。适度的或可控的炎症对于入侵病原微生物的清除以及受损组织的修复是必需的,然而过度的或不可控的炎症往往会导致病理性炎症反应发生,大大提高了各种感染性和代谢性疾病的发病风险。多不饱脂肪酸代谢生成的脂质调控介质对炎症的启动、发展以及消退均具有重要的调节作用,了解多不和脂肪酸的代谢及其代谢产物对炎症反应的调节机制,对于通过饲粮营养途径控制疾病发生以及改善人和动物健康具有重要的理论和现实意义。鉴此,本文综述了多不饱和脂肪酸的代谢途径,并就其代谢产物对炎症反应的调节进行了详细论述。

本文引用格式

弓剑 , 晓敏 . 多不饱和脂肪酸代谢及其对炎症的调节[J]. 动物营养学报, 2017 , 29(1) : 1 -7 . DOI: 10.3969/j.issn.1006-267x.2017.01.001

Abstract

Inflammation is part of protective response to infection or tissue injury. Appropriate or controlled inflammation is necessary to eliminate invading pathogens and repair damaged tissue. However, excessive or uncontrolled inflammation contributes to a range of pathological inflammatory responses, which may result in the increased incidence of both metabolic and infectious diseases. Lipid mediators derived from polyunsaturated fatty acids have important roles in regulating the initiation, development and resolving of inflammatory responses. A better understanding of the metabolism of polyunsaturated fatty acids and its regulation to inflammation will facilitate the development of dietary nutritional strategies to control the incidence of diseases and improve human and animal health. Therefore, the metabolic pathways of polyunsaturated fatty acids and the regulatory mechanism of its metabolic products to inflammation were reviewed in this paper.

参考文献

[1] SIMONS K,TOOMRE D.Lipid rafts and signal transduction[J].Nature Reviews Molecular Cell Biology,2000,1(1):31-39.  
[2] STILLWELL W,WASSALL S R.Docosahexaenoic acid:membrane properties of a unique fatty acid[J].Chemistry and Physics of Lipids,2003,126(1):1-27.  
[3] DUMLAO D S,BUCZYNSKI M W,NORRIS P C,et al.High-throughput lipidomic analysis of fatty acid derived eicosanoids and N-acylethanolamines[J].Biochimica et Biophysica Acta:Molecular and Cell Biology of Lipids,2011,1811(11):724-736.  
[4] POULSEN R C,GOTLINGER K H,SERHAN C N,et al.Identification of inflammatory and proresolving lipid mediators in bone marrow and their lipidomic profiles with ovariectomy and omega-3 intake[J].American Journal of Hematology,2008,83(6):437-445.  
[5] CALDER P C.Polyunsaturated fatty acids and inflammation[J].Prostaglandins,Leukotrienes and Essential Fatty Acids,2006,75(3):197-202.  
[6] CALDER P C.n-3 polyunsaturated fatty acids,inflammation,and inflammatory diseases[J].World Review of Nutrition and Dietetics,2006,83(6):S1505-1519S.
[7] KUHN H,BANTHIYA S,VAN LEYEN K.Mammalian lipoxygenases and their biological relevance[J].Biochimica et Biophysica Acta:Molecular and Cell Biology of Lipids,2015,1851(4):308-330.  
[8] ASTUDILLO A M,BALGOMA D,BALBOA M A,et al.Dynamics of arachidonic acid mobilization by inflammatory cells[J].Biochimica et Biophysica Acta:Molecular and Cell Biology of Lipids,2012,1821(2):249-256.  
[9] MILNE G L,YIN H Y,HARDY K D,et al.Isoprostane generation and function[J].Chemical Reviews,2011,111(10):5973-5996.  
[10] BOUTET P,BUREAU F,DEGAND G,et al.Imbalance between lipoxin A4 and leukotriene B4 in chronic mastitis-affected cows[J].Journal of Dairy Science,2003,86(11):3430-3439.  
[11] MAVANGIRA V,GANDY J C,ZHANG C,et al.Polyunsaturated fatty acids influence differential biosynthesis of oxylipids and other lipid mediators during bovine coliform mastitis[J].Journal of Dairy Science,2015,98(9):6202-6215.  
[12] RYMAN V E,PIGHETTI G M,LIPPOLIS J D,et al.Quantification of bovine oxylipids during intramammary Streptococcus uberis infection[J].Prostaglandins & Other Lipid Mediators,2015,121:207-217.
[13] BAGGA D,WANG L,FARIAS-EISNER R,et al.Differential effects of prostaglandin derived from ω-6 and ω-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion[J].Proceedings of the National Academy of Sciences of the United States of America,2003,100(4):1751-1756.  
[14] SERHAN C N,CHIANG N.Endogenous pro-resolving and anti-inflammatory lipid mediators:a new pharmacologic genus[J].British Journal of Pharmacology,2008,153(Suppl.1):S200-S215.
[15] SORDILLO L M.Nutritional strategies to optimize dairy cattle immunity[J].Journal of Dairy Science,2016,99(6):4967-4982.  
[16] PATTANAIK U,PRASAD K.Oxygen free radicals and endotoxic shock:effect of flaxseed[J].Journal of Cardiovascular Pharmacology and Therapeutics,1998,3(4):305-318.  
[17] SERHAN C N.Systems approach to inflammation resolution:Identification of novel anti-inflammatory and pro-resolving mediators[J].Journal of Thrombosis and Haemostasis,2009,7:44-48.
[18] CHINTHAMANI S,ODUSANWO O,MONDAL N,et al.Lipoxin A4 inhibits immune cell binding to salivary epithelium and vascular endothelium[J].American Journal of Physiology:Cell Physiology,2012,302(7):C968-C978.
[19] ALTMANN R,HAUSMANN M,SPÖTTL T,et al.13-Oxo-ODE is an endogenous ligand for PPARγ in human colonic epithelial cells[J].Biochemical Pharmacology,2007,74(4):612-622.  
[20] NATARAJAN R,REDDY M A,MALIK K U,et al.Signaling mechanisms of nuclear factor-κB-mediated activation of inflammatory genes by 13-hydroperoxyoctadecadienoic acid in cultured vascular smooth muscle cells[J].Arteriosclerosis,Thrombosis,and Vascular Biology,2001,21(9):1408-1413.  
[21] BONOMINI F,TENGATTINI S,FABIANO A,et al.Atherosclerosis and oxidative stress[J].Histology and Histopathology,2008,23(3):381-390.
[22] RAMSDEN C E,RINGEL A,FELDSTEIN A E,et al.Lowering dietary linoleic acid reduces bioactive oxidized linoleic acid metabolites in humans[J].Prostaglandins,Leukotrienes and Essential Fatty Acids,2012,87(4/5):135-141.
[23] QUEHENBERGER O,ARMANDO A M,BROWN A H,et al.Lipidomics reveals a remarkable diversity of lipids in human plasma[J].The Journal of Lipid Research,2010,51(11):3299-3305.  
[24] SERHAN C N,CLISH C B,BRANNON J,et al.Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing[J].The Journal of Experimental Medicine,2000,192(8):1197-1204.  
[25] SERHAN C N,HONG S,GRONERT K,et al.A family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals[J].The Journal of Experimental Medicine,2002,196(8):1025-1037.  
[26] SERHAN C N,YANG R,MARTINOD K,et al.Maresins:novel macrophage mediators with potent antiinflammatory and proresolving actions[J].The Journal of Experimental Medicine,2009,206(1):15-23.  
[27] LEE T H,MENCIA-HUERTA J M,SHIH C,et al.Effects of exogenous arachidonic,eicosapentaenoic,and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils[J].Journal of Clinical Investigation,1984,74(6):1922-1933.  
[28] SCHWAB J M,CHIANG N,ARITA M,et al.Resolvin E1 and protectin D1 activate inflammation-resolution programmes[J].Nature,2007,447(7146):869-874.  
[29] HASTURK H,KANTARCI A,GOGUET-SURMENIAN E,et al.Resolvin E1 regulates inflammation at the cellular and tissue level and restores tissue homeostasis in vivo[J].The Journal of Immunology,2007,179(10):7021-7029.  
[30] TJONAHEN E,OH S F,SIEGELMAN J,et al.Resolvin E2:identification and anti-inflammatory actions:pivotal role of human 5-lipoxygenase in resolvin E series biosynthesis[J].Chemistry & Biology,2006,13(11):1193-1202.  
[31] EICKMEIER O,SEKI H,HAWORTH O,et al.Aspirin-triggered resolvin D1 reduces mucosal inflammation and promotes resolution in a murine model of acute lung injury[J].Mucosal Immunology,2013,6(2):256-266.  
[32] DONG J J,LIAO Z L,WANG T,et al.Resolvin-D1 inhibits interleukin-8 and hydrogen peroxide production induced by cigarette smoke extract in 16HBE cells via attenuating NF-κB activation[J].Chinese Medical Journal,2014,127(3):511-517.
[33] BOHR S,PATEL S J,SARIN D,et al.Resolvin D2 prevents secondary thrombosis and necrosis in a mouse burn wound model[J].Wound Repair and Regeneration,2013,21(1):35-43.  
[34] DEMARQUOY J,BORGNE F L.Biosynthesis, metabolism and function of protectins and resolvins[J].Clinical Lipidology,2014,9(6):683-693.  
[35] ARIEL A,SERHAN C N.New lives given by cell death:macrophage differentiation following their encounter with apoptotic leukocytes during the resolution of inflammation[J].Frontiers in Immunology,2012,3:4.
[36] DALLI J,SERHAN C N.Specific lipid mediator signatures of human phagocytes:microparticles stimulate macrophage efferocytosis and pro-resolving mediators[J].Blood,2012,120(15):e60-e72.
[37] NORDGREN T M,BAUER C D,HEIRES A J,et al.Maresin-1 reduces airway inflammation associated with acute and repetitive exposures to organic dust[J].Translational Research,2015,166(1):57-69.  
[38] GONG J,WU Z Y,QI H,et al.Maresin 1 mitigates LPS-induced acute lung injury in mice[J].British Journal of Pharmacology,2014,171(14):3539-3550.  
[39] DALLI J,ZHU M,VLASENKO N A,et al.The novel 13S,14S-epoxy-maresin is converted by human macrophages to maresin 1(MaR1),inhibits leukotriene A4 hydrolase (LTA4H),and shifts macrophage phenotype[J].The FASEB Journal,2013,27(7):2573-2583.  
[40] MARCON R,BENTO A F,DUTRA R C,et al.Maresin 1,a proresolving lipid mediator derived from omega-3 polyunsaturated fatty acids,exerts protective actions in murine models of colitis[J].The Journal of Immunology,2013,191(8):4288-4298.  
文章导航

/